D
CRISPR Therapeutics AG CRSP
$41.86 $3.298.53% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Total Cash And Short-Term Investments 1.86B 1.90B 1.94B 2.00B 2.11B
Total Receivables -- 27.10M -- -- --
Inventory -- -- -- -- --
Prepaid Expenses 8.83M 6.21M 8.25M 8.79M 11.50M
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets 3.50M -- -- -- --
Total Current Assets 1.87B 1.94B 1.94B 2.01B 2.12B

Total Current Assets 1.87B 1.94B 1.94B 2.01B 2.12B
Net Property, Plant & Equipment 269.70M 277.55M 284.83M 291.57M 298.51M
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- 2.00K
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 28.79M 27.35M 27.41M 26.66M 20.88M
Total Assets 2.17B 2.24B 2.26B 2.34B 2.44B

Total Accounts Payable 13.06M 14.71M 15.58M 9.45M 16.46M
Total Accrued Expenses 28.29M 39.41M 35.55M 39.05M 103.70M
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current 17.51M 17.29M 16.88M 16.45M 15.99M
Total Finance Division Other Current Liabilities 60.59M 16.38M 21.80M 62.87M 69.37M
Total Other Current Liabilities 60.59M 16.38M 21.80M 62.87M 69.37M
Total Current Liabilities 119.45M 87.78M 89.81M 127.82M 118.99M

Total Current Liabilities 119.45M 87.78M 89.81M 127.82M 118.99M
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases 201.85M 206.41M 210.66M 214.85M 218.94M
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities 15.64M 15.77M 16.00M 16.23M 17.16M
Total Liabilities 336.94M 309.95M 316.47M 358.90M 355.08M

Common Stock & APIC 3.33B 3.30B 3.26B 3.23B 3.20B
Retained Earnings -1.50B -1.37B -1.33B -1.24B -1.12B
Treasury Stock & Other 4.07M 1.78M 10.50M -2.94M -1.61M
Total Common Equity 1.83B 1.93B 1.94B 1.98B 2.08B

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 1.83B 1.93B 1.94B 1.98B 2.08B
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 1.83B 1.93B 1.94B 1.98B 2.08B